Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.

Home/Biomarker

BRAF non-V600 — resistance to vemurafenib

Gene: BRAF · Type: mutation

Indications: Melanoma

FDA Resistance Assertions

Drug	Indication	Recommendation	FDA Source	Link
Vemurafenib	Melanoma	NOT RECOMMENDED	FDA Label	Label